The Pharmacy Times® Immunization resource center provides the latest news in immunization. Here, you’ll find information about upcoming conferences and meetings, updated clinical trial listings, and other resources for those interested in vaccination.
Pharmacy Times® interviewed Fred Peruggia, the head of marketing for respiratory and biologics vaccines at AstraZeneca, on the company’s production and distribution of an intranasal flu vaccine for this flu season.
Despite the looming uncertainty of whether children will return to the classroom or remain educated at home, it is still important to remind parents that they should confirm their children are up-to-date on their vaccinations.
Currently, a total of 2612 vaccines are being investigated for a number of infectious diseases, including Zika, Ebola, Lassa, Nipah, Middle East respiratory syndrome coronavirus (MERS-CoV), HIV, and coronavirus disease 2019 (COVID-19).
Pharmacists have become widely accepted as immunization advocates, educators, and administrators, and an increasing proportion of influenza vaccines are being administered in community pharmacies nationwide.
Counseling pearls and considerations for the shingles vaccine, such as navigating insurance coverage, managing adverse events, and handling a missed dose in the series, are discussed.
The Pharmacy Times® Immunization resource center acts as a hub for all the latest clinical information pertaining to vaccines, with articles covering live-attenuated vaccines; inactivated vaccines; subunit, recombinant, polysaccharide; and conjugate vaccines. Here, pharmacists will find content surrounding the data from all phases of clinical trials and studies in the immunization, and information and coverage straight from the floor of from the ongoing conferences and annual meetings.